|
|
|
LifeScienceHistory.com - Check us out on Instagram
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
AURA Biosciences, Inc.
| | | Phone: | (617) 401-3360 | Fax: | (617) 401-3762 | Year Established: | 2007 | Main Contact: | Elisabet de los Pinos, Founder & CEO | | Other Contacts: | Denis O'Shaughnessy, Ph.D., VP, Clinical Development Michele Keough, Senior VP, Project Management and Device Supply Chain Stephen Monks, Ph.D., Senior VP, Development Mike Wyzga, CFO Alison Lawton, COO
| | Company Description | Aura is is a next-generation biotech company developing the Nanosmart™ platform for the delivery of nano-enabled drugs. Nanosmart solves critical issues in drug delivery by encapsulating therapies within protein nanoparticles engineered for precise targeting, immune system evasion, and efficient cellular uptake. Aura is applying Nanosmart to two important areas, the well-studied area of chemotherapeutics and the emerging field of RNAi. With an initial focus on pancreatic cancer, Aura’s goal is to increase patient survival rates by making chemotherapy better tolerated and more efficacious. | |
|
|
|
|
|